
Canine Health
Chondrofocus Tablets (Small Breed)


Chondrofocus acts as a nutritional aid in the prevention and management of intervertebral disc disease (ivdd) in small breed dogs.
Composition
EACH TABLET CONTAINS:
| Ingredient | Amount |
|---|---|
| Resveratrol | 50mg |
| ASU (Avocado-Soybean Unsaponifiables) | 40mg |
| MSM | 30mg |
| Sodium Ascorbate | 10mg |
| α -Tocopheryl Acetate | 175IU |
| Excipients | 215mg |
Directions For Use
Safety Margins
| Age Group | Recommendation | Rationale |
|---|---|---|
| < 8 Weeks | Not recommended. | Immature hepatic & enzymatic pathways; no safety data for resveratrol or ASU in neonates. |
| 8–12 Weeks | Use only under veterinary supervision at ½ dose if congenital spinal risk identified (e.g., chondrodystrophic breeds). | Early antioxidant/chondroprotective benefit possible, but metabolism of ASU and MSM still maturing. |
| ≥ 12 Weeks (3 Months) | Safe for general use per label. | All ingredients have documented tolerance in juvenile dogs beyond the weaning stage; supports early disc and cartilage resilience. |
Advantages
Packaging
100 Tablets